Sinemet is a prescription medication used to treat Parkinson’s disease. It combines two active ingredients: levodopa, which the brain converts into dopamine, and carbidopa, which prevents levodopa from breaking down before it reaches the brain. Beyond Parkinson’s, Sinemet is also approved for parkinsonism caused by encephalitis, carbon monoxide poisoning, or manganese poisoning.
How Sinemet Works in the Brain
Parkinson’s disease develops when the brain loses cells that produce dopamine, a chemical messenger essential for smooth, coordinated movement. As dopamine levels drop, symptoms like tremor, stiffness, and slowness emerge. Levodopa, the primary ingredient in Sinemet, crosses into the brain and gets converted into dopamine, replenishing what the disease has taken away.
The second ingredient, carbidopa, plays a supporting role. Without it, most of the levodopa you swallow would be broken down in the body before ever reaching the brain, causing nausea and wasting the drug’s potential. Carbidopa blocks that premature breakdown, allowing more levodopa to arrive where it’s needed. This is why the two are always given together.
Carbidopa-levodopa remains the most effective medication for controlling Parkinson’s motor symptoms. The American Academy of Neurology’s practice guideline on treating motor symptoms of early Parkinson’s disease, reaffirmed in February 2025, continues to evaluate levodopa alongside dopamine agonists and other drug classes, and levodopa remains the standard against which other treatments are measured.
What Symptoms It Treats
Sinemet targets the core motor symptoms of Parkinson’s disease: tremor at rest, muscle rigidity, slowness of movement (sometimes called bradykinesia), and problems with balance and walking. Most people notice improvement in stiffness and slowness first. Tremor can also improve, though the response varies from person to person.
The medication can also help with some non-motor effects tied to dopamine loss, such as the soft, monotone voice and reduced facial expression that often accompany Parkinson’s. It does not, however, treat all features of the disease. Symptoms driven by changes outside the dopamine system, like certain cognitive difficulties or blood pressure drops, typically require different approaches.
Common Side Effects
Nausea is the most frequently reported side effect, especially when starting treatment or increasing the dose. Taking Sinemet with a small, low-protein snack like crackers can help settle the stomach without significantly interfering with absorption. Fatigue and dizziness, including lightheadedness from low blood pressure when standing up, are also common early on and often ease as the body adjusts.
At higher doses or after longer use, some people develop involuntary, dance-like movements called dyskinesias. These extra movements, which can affect the arms, legs, head, or trunk, are a side effect of the levodopa itself. They differ from Parkinson’s tremor and tend to appear when dopamine levels in the brain peak after a dose. Hallucinations can also occur, particularly in older adults or those on higher doses, and should be reported to a prescriber promptly.
Motor Fluctuations Over Time
In the early years of treatment, Sinemet typically provides smooth, reliable symptom control throughout the day. As Parkinson’s progresses, the brain’s ability to store and regulate dopamine declines further, and the medication’s effects become less predictable. This shift is known as motor fluctuations.
The most common pattern is “wearing off,” where a dose stops working before the next one is due, and symptoms creep back between doses. Some people experience more abrupt swings, toggling between “on” periods when the medication is working well and “off” periods when stiffness and slowness return with little warning. These fluctuations are driven partly by disease progression and partly by how levodopa is absorbed. Constipation, which is common in Parkinson’s, can slow the drug’s journey through the digestive tract and contribute to unreliable absorption.
Prescribers have several strategies for managing these fluctuations, including adjusting dose timing, switching to extended-release formulations, or adding other medications that help stabilize dopamine levels between doses.
Why Protein and Meal Timing Matter
Levodopa is absorbed through the wall of the small intestine using the same transport system that carries amino acids from dietary protein. When you eat a protein-rich meal around the same time as your dose, amino acids compete with the drug for those transporters, and less levodopa makes it into the bloodstream and brain. This is called the “protein effect,” and for some people it noticeably blunts the medication’s benefit.
The standard recommendation is to take Sinemet 30 minutes before a meal or one to two hours after eating. If the protein effect is a significant problem, two strategies can help. The first is saving most of your daily protein for dinner so that your active daytime hours aren’t affected. The second is spreading protein evenly across all meals so absorption stays consistent rather than fluctuating unpredictably. Either approach is worth discussing with your care team if you notice that meals seem to interfere with your medication.
Available Formulations
Sinemet comes in immediate-release tablets with different ratios of carbidopa to levodopa. The most commonly prescribed starting dose is one 25/100 tablet (25 mg of carbidopa and 100 mg of levodopa) taken three times a day. The dose is gradually adjusted based on symptom control and tolerance, up to a typical maximum of eight tablets per day.
An extended-release version, Sinemet CR, dissolves more slowly and is designed to provide a longer duration of effect per dose. This can be helpful for people experiencing wearing-off between doses or who need overnight coverage for morning stiffness. Other formulations of carbidopa-levodopa are also available, including orally disintegrating tablets and an intestinal gel for advanced Parkinson’s, though these go by different brand names.
Who Should Not Take Sinemet
People taking a class of older antidepressants called non-selective MAO inhibitors cannot use Sinemet, because the combination can cause dangerous spikes in blood pressure. These medications must be stopped at least two weeks before starting Sinemet. Selective MAO-B inhibitors, which are actually used to treat Parkinson’s, are a different class and are generally safe to combine with carbidopa-levodopa.
Sinemet is also not appropriate for people with narrow-angle glaucoma. Those with a history of melanoma, heart disease, peptic ulcers, or psychiatric conditions need careful evaluation before starting treatment, as the medication can worsen certain underlying conditions. A full medication review is important because levodopa interacts with several drug classes beyond antidepressants, including certain blood pressure medications and antipsychotics.